HEADER HYDROLASE(SERINE PROTEINASE) 01-FEB-93 2HAT OBSLTE 27-FEB-95 2HAT 3HAT TITLE THE STRUCTURE OF A DESIGNED PEPTIDOMIMETIC INHIBITOR TITLE 2 COMPLEX OF ALPHA-THROMBIN COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: L; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE:; COMPND 7 CHAIN: H; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE:; COMPND 11 CHAIN: I; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE:; COMPND 15 CHAIN: T; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 MOL_ID: 2; SOURCE 3 MOL_ID: 3; SOURCE 4 MOL_ID: 4 KEYWDS HYDROLASE(SERINE PROTEINASE) EXPDTA X-RAY DIFFRACTION AUTHOR T.-P.WU,A.TULINSKY REVDAT 1 31-JAN-94 2HAT 0 JRNL AUTH T.-P.WU,V.YEE,A.TULINSKY,R.A.CHRUSCIEL,H.NAKANISHI, JRNL AUTH 2 R.SHEN,C.PRIEBE,M.KAHN JRNL TITL THE STRUCTURE OF A DESIGNED PEPTIDOMIMETIC JRNL TITL 2 INHIBITOR COMPLEX OF ALPHA-THROMBIN JRNL REF PROTEIN ENG. V. 6 471 1993 JRNL REFN ASTM PRENE9 UK ISSN 0269-2139 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.NAKANISHI,R.A.CHRUSCIEL,R.SHEN,S.BERTENSHAW, REMARK 1 AUTH 2 M.E.JOHNSON,T.J.RYDEL,A.TULINSKY,M.KAHN REMARK 1 TITL PEPTIDE MIMETICS OF THE THROMBIN-BOUND STRUCTURE REMARK 1 TITL 2 OF FIBRINOPEPTIDE A REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 89 1705 1992 REMARK 1 REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 1 REFERENCE 2 REMARK 1 AUTH F.NI,Y.C.MEINWALD,M.VASQUEZ,H.A.SCHERAGA REMARK 1 TITL HIGH-RESOLUTION NMR STUDIES OF FIBRINOGEN-LIKE REMARK 1 TITL 2 PEPTIDES IN SOLUTION: STRUCTURE OF A REMARK 1 TITL 3 THROMBIN-BOUND PEPTIDE CORRESPONDING TO RESIDUES REMARK 1 TITL 4 7-16 OF THE A ALPHA CHAIN OF HUMAN FIBRINOGEN REMARK 1 REF BIOCHEMISTRY V. 28 3094 1989 REMARK 1 REFN ASTM BICHAW US ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.KAHN,S.WILKE,B.CHEN,K.FUJITA REMARK 1 TITL NONPEPTIDE MIMETICS OF BETA-TURNS: A FACILE REMARK 1 TITL 2 OXIDATIVE INTRAMOLECULAR CYCLOADDITION OF AN REMARK 1 TITL 3 AZODICARBONYL SYSTEM REMARK 1 REF J.AM.CHEM.SOC. V. 110 1638 1988 REMARK 1 REFN ASTM JACSAT US ISSN 0002-7863 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ 2HAT REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 10139 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.143 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2398 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 172 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.016 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.044 ; 0.035 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.049 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.010 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.180 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.220 ; 0.500 REMARK 3 MULTIPLE TORSION (A) : 0.320 ; 0.500 REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : 0.290 ; 0.500 REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 2.000 ; 3.000 REMARK 3 STAGGERED (DEGREES) : 24.000; 15.000 REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.100 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.700 ; 2.500 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.600 ; 2.500 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HAT COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 2HAT THROMBIN IS CLEAVED BETWEEN RESIDUES 15 AND 16. CHAIN REMARK 5 2HAT INDICATOR *L* IS USED FOR RESIDUES 1H - 15 AND CHAIN REMARK 5 2HAT INDICATOR *H* IS USED FOR RESIDUES 16 - 247. CHAIN REMARK 5 2HAT INDICATOR *I* IS USED FOR HIRUGEN, THE CARBOXYL REMARK 5 TERMINUS OF 2HAT HIRUDIN, WHICH OCCUPIES THE EXOSITE. CHAIN REMARK 5 INDICATOR *T* 2HAT IS USED FOR FPAM, A DESIGNED REMARK 5 PEPTIDOMIMETIC INHIBITOR, 2HAT WHICH OCCUPIES THE ACTIVE REMARK 5 SITE OF ALPHA THROMBIN. 2HAT REMARK 6 REMARK 6 2HAT THE ELECTRON DENSITY MAPS SHOWED NO DENSITY FOR REMARK 6 RESIDUES 2HAT THR L 1H - GLU L 1C AND PHE H 254 - GLU H REMARK 6 247. 2HAT REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 1/2+X,1/2+Y,Z REMARK 290 4555 1/2-X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.56500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.21500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.56500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.21500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 4 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, I, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH 410 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR H 146A REMARK 465 TRP H 146B REMARK 465 THR H 146C REMARK 465 ALA H 146D REMARK 465 ASN H 146E REMARK 465 VAL H 146F REMARK 465 GLY H 146G REMARK 465 LYS H 146H REMARK 465 MBN T 1 REMARK 465 ABN T 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG L 14D CG CD NE CZ NH1 NH2 REMARK 470 ASN H 62 CB CG OD1 ND2 REMARK 470 LYS H 110 CB CG CD CE NZ REMARK 470 GLN H 151 CB CG CD OE1 NE2 REMARK 470 GLU H 192 CB CG CD OE1 OE2 REMARK 470 GLN H 244 CG CD OE1 NE2 REMARK 470 PHE H 245 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU H 247 CB CG CD OE1 OE2 REMARK 470 GLU I 58 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 NH1 ARG L 15 O PHE H 204A 1.49 REMARK 500 C ARG T 6 CH CH3 T 6 1.53 REMARK 500 CM MBN T 1 N ABN T 2 1.53 REMARK 500 CB RNG T 3 C ABN T 2 1.57 REMARK 500 OH TYR I 63 S SFN I 53 1.68 REMARK 500 O HOH 421 O HOH 512 1.92 REMARK 500 NH2 ARG H 75 O HOH 809 1.97 REMARK 500 O LYS H 224 O HOH 429 2.06 REMARK 500 N SER L 1E O LEU H 123 2.08 REMARK 500 OG SER H 195 O ARG T 6 2.15 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O GLY L 14M NH1 ARG H 173 4556 1.12 REMARK 500 O ASP L 14L NH1 ARG H 173 4556 1.71 REMARK 500 CD ARG H 75 CD ARG H 75 2555 1.80 REMARK 500 C GLY L 14M NH1 ARG H 173 4556 1.90 REMARK 500 O ASP H 170 O HOH 579 4546 2.14 REMARK 500 O GLY L 14M CZ ARG H 173 4556 2.15 REMARK 500 CZ ARG L 15 O THR H 172 4556 2.18 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER L 1E 92.05 103.15 REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 583 DISTANCE = 5.54 ANGSTROMS REMARK 525 HOH 598 DISTANCE = 6.39 ANGSTROMS REMARK 525 HOH 657 DISTANCE = 10.16 ANGSTROMS REMARK 525 HOH 680 DISTANCE = 5.03 ANGSTROMS REMARK 525 HOH 717 DISTANCE = 7.38 ANGSTROMS REMARK 525 HOH 806 DISTANCE = 8.21 ANGSTROMS REMARK 525 HOH 814 DISTANCE = 7.35 ANGSTROMS REMARK 525 HOH 866 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH 904 DISTANCE = 11.17 ANGSTROMS SEQRES 1 L 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 L 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 L 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 H 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 H 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 H 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 H 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 H 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 H 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 H 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 H 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 H 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 H 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 H 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 H 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 H 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 H 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 H 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 H 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 H 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 H 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 H 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 H 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 I 10 GLY PHE GLU GLU ILE PRO GLU GLU TYR LEU SEQRES 1 T 6 MBN ABN RNG GLY VAL ARG FTNOTE 1 CIS PROLINE - PRO H 37 FTNOTE 2 RESIDUE TYR I 63 IS SULFONATED. FTNOTE 3 RESIDUE ARG T 6 IS METHYLATED. HET RNG T 3 16 HET SFN I 53 4 HET MBN T 1 7 HET ABN T 2 8 HET CH3 T 6 1 HETNAM RNG (6,10-DIOXO-OCTAHYDRO-PYRIDAZINO[1,2-A][1,2]DIAZEPIN- HETNAM 2 RNG 1-YL)-ACETALDEHYDE FRAGMENT HETNAM SFN SULFONATE GROUP HETNAM MBN TOLUENE HETNAM ABN BENZYLAMINE HETNAM CH3 METHYL GROUP HETSYN RNG FUSED RING FRAGMENT OF INHIBITOR FORMUL 4 RNG C11 H16 N2 O3 FORMUL 5 SFN H O3 S 1- FORMUL 6 MBN C7 H8 FORMUL 7 ABN C7 H9 N FORMUL 8 CH3 C H4 FORMUL 9 HOH *172(H2 O1) HELIX 1 1 PHE L 7 SER L 11 5 5 HELIX 2 2 THR L 14B SER L 14I 1 8 HELIX 3 3 ALA H 55 CYS H 58 5 4 HELIX 4 4 PRO H 60B ASP H 60E 5 4 HELIX 5 5 THR H 60I ASN H 62 5 3 HELIX 6 6 ASP H 125 LEU H 130 1 9 HELIX 7 7 GLU H 164 ASP H 170 1 7 HELIX 8 8 LEU H 234 ASP H 243 1 10 SHEET 1 A 8 SER H 20 ASP H 21 0 SHEET 2 A 8 GLN H 156 VAL H 163 -1 O VAL H 157 N SER H 20 SHEET 3 A 8 MET H 180 ALA H 183 -1 O CYS H 182 N VAL H 163 SHEET 4 A 8 GLY H 226 HIS H 230 -1 O GLY H 226 N ALA H 183 SHEET 5 A 8 TRP H 207 TRP H 215 -1 N ILE H 212 O THR H 229 SHEET 6 A 8 PRO H 198 LYS H 202 -1 N MET H 201 O TYR H 208 SHEET 7 A 8 LYS H 135 GLY H 140 -1 N ARG H 137 O VAL H 200 SHEET 8 A 8 GLN H 156 VAL H 163 -1 O VAL H 158 N VAL H 138 SHEET 1 B 7 GLN H 30 ARG H 35 0 SHEET 2 B 7 GLU H 39 LEU H 46 -1 O LEU H 41 N LEU H 33 SHEET 3 B 7 TRP H 51 THR H 54 -1 O LEU H 53 N SER H 45 SHEET 4 B 7 ALA H 104 LEU H 108 -1 O ALA H 104 N THR H 54 SHEET 5 B 7 LYS H 81 ILE H 90 -1 N TYR H 89 O LEU H 105 SHEET 6 B 7 LEU H 64 ILE H 68 -1 N VAL H 66 O SER H 83 SHEET 7 B 7 GLN H 30 ARG H 35 -1 N PHE H 34 O LEU H 65 SHEET 1 C 2 LEU H 60 TYR H 60A 0 SHEET 2 C 2 LYS H 60F ASN H 60G-1 O LYS H 60F N TYR H 60A SSBOND 1 CYS L 1 CYS H 122 SSBOND 2 CYS H 42 CYS H 58 SSBOND 3 CYS H 168 CYS H 182 SSBOND 4 CYS H 191 CYS H 220 CISPEP 1 SER H 36A PRO H 37 0 -0.59 SITE 1 CAT 3 HIS H 57 ASP H 102 SER H 195 CRYST1 71.130 72.430 73.000 90.00 101.09 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014059 0.000000 0.002756 0.00000 SCALE2 0.000000 0.013806 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013959 0.00000